<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201213049703N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-02-10</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>Effect of herbal ointment in treatment of ulcers diabetes</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of efficacy of herbal ointment containing aqueous extract Scrophularia Straita Boiss, Honey , Sativa Nigella oil ,Mazo, Apple Vinegar in treatment of ulcers diabetes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52998</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization and assigning people to groups The random number function is used using Excel software as follows: First, in a column, the groups are entered as A, B and below. In the opposite column, random numbers are generated using the RAND command. In the next step, using the sort command, random numbers are generated from small to large or vice versa, which causes the order of the groups, A, B, to be changed. Using the new order, people are assigned to different groups, Blinding description: Herbal ointments and routine treatment ointments are designed to be the same in terms of color and odor so that they are not recognizable to the patient and the caregiver. And only the statistical analyst should be aware of the ointment used.</study_design>
      <phase>3</phase>
      <hc_freetext>Ulcers diabetes.</hc_freetext>
      <i_freetext>Intervention 1: The herbal ointment of the design containing thirsty plant extract, honey, black seed oil, mazo will be provided to the patients of the intervention group in the form of ready-to-use tubes without printing of the design. Contains thirst extract, apple cider vinegar and normal saline, washed and dried with sterile gauze. The herbal ointment is then applied to the wound with a watering can and fixed with a four-layer sterile dry gauze with anti-allergy adhesive. Changing the dressing and using the ointment should be done once a day for the necessary time. (Depending on the patient's condition until complete treatment). Intervention 2: Liam topical ointment (manufacturer of Mehr Miracle Researchers) containing chamomile extract, 8% cow's eye, 13% beeswax and 17% honey as a routine ointment of Imam Khomeini Hospital in Kermanshah in the form of ready-to-use tubes without printing. Patients in intervention group 2 will be included. The procedure will be performed by washing the wound and surrounding tissues with normal saline solution and drying them with sterile gauze. Liam ointment is then applied to the wound with a watering can and fixed with a four-layer sterile dry gauze with anti-allergy adhesive. Changing the dressing and using the ointment should be done once a day for the necessary time. (Depending on the patient's condition until complete treatment).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Results can be shared after not identifying people.

When:
Access period starts 6 months after the results are published

To whom:
All interested people

Conditions:
For the use of other researchers

Where to obtain:
Toraj Ahmadi Jouybari
dr.ahmadi_jouybari@yahoo.com

How to obtain:
1. Send request to email
2. The purpose of the data request should be clear.
3. If approved by the main executor, action will be taken immediately

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Toraj Ahmadi Jouybari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kermanshah - Naghlieh Ave - Imam Khomeini Hospital, Kermanshah</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6718743161</zip>
        <telephone>+98 83 3727 2049</telephone>
        <email>dr.ahmadi_jourbari@yahoo.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Toraj Ahmadi Jouybari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kermanshah - Imam Khomeini Hospital, Kermanshah</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6718743161</zip>
        <telephone>+98 83 3727 2049</telephone>
        <email>dr.ahmadi_jourbari@yahoo.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with diabetic ulcers</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnant women
Patients suffering from liver and kidney failure
Childern
People undergoing chemotherapy
People receiving corticosteroids.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E11.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Type 2 diabetes mellitus with neurological complications</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The herbal ointment of the design containing thirsty plant extract, honey, black seed oil, mazo will be provided to the patients of the intervention group in the form of ready-to-use tubes without printing of the design. Contains thirst extract, apple cider vinegar and normal saline, washed and dried with sterile gauze. The herbal ointment is then applied to the wound with a watering can and fixed with a four-layer sterile dry gauze with anti-allergy adhesive. Changing the dressing and using the ointment should be done once a day for the necessary time. (Depending on the patient's condition until complete treatment)</i_keyword>
      <i_keyword>Liam topical ointment (manufacturer of Mehr Miracle Researchers) containing chamomile extract, 8% cow's eye, 13% beeswax and 17% honey as a routine ointment of Imam Khomeini Hospital in Kermanshah in the form of ready-to-use tubes without printing. Patients in intervention group 2 will be included. The procedure will be performed by washing the wound and surrounding tissues with normal saline solution and drying them with sterile gauze. Liam ointment is then applied to the wound with a watering can and fixed with a four-layer sterile dry gauze with anti-allergy adhesive. Changing the dressing and using the ointment should be done once a day for the necessary time. (Depending on the patient's condition until complete treatment)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>PUSH Score. Timepoint: Every week until the 12th week. Method of measurement: Based on the characteristics of diabetic ulcers.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Wound area. Timepoint: Every week until the 12th week. Method of measurement: With a caliper, the dimensions of the wound, including the length and width of the wound, are measured and its area is calculated.</sec_outcome>
      <sec_outcome>Wound depth. Timepoint: Every week until the 12th week. Method of measurement: Wound depth is measured with forceps and calipers.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-04-11</approval_date>
        <contact_name>Ethics committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Kermanshah, Shahid Beheshti Blvd., Kermanshah University of Medical Sciences Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
